Real-world bleeding rates on emicizumab: the value of using nationwide digital treatment diary data in clinical research

Background: People with hemophilia in the Netherlands log bleeds and infusions through a digital treatment diary. With the current innovations in hemophilia treatments, the use of patient-reported bleeding data will become increasingly important. Objective: To assess real-world bleeding rates on emi...

Descripción completa

Detalles Bibliográficos

Autores principales:	Martijn R. Brands, Elisabeth M. Taal, Martijn Oude Voshaar, Mariëtte H.E. Driessens, Caroline M.E. van Veen, Marieke J.H.A. Kruip, Paul L. den Exter, Britta A.P. Laros-van Gorkom, Marjet A. Stein-Wit, Kathelijn Fischer, Stephan Meijer, Karina Meijer, Marlène Beijlevelt, Karin Fijnvandraat, Samantha C. Gouw
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2025-02-01
Colección:	Research and Practice in Thrombosis and Haemostasis
Materias:	emicizumab hemophilia A patient-generated health data registries telemedicine
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S247503792500041X
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!